Omada Health CFO exercises options, sells 5,800 shares
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an exercise-and-sell transaction dated July 13, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an exercise-and-sell transaction dated July 13, 2026. He exercised options for 5,800 common shares at $8.2800 per share and sold 5,800 common shares in open-market trades at $24.0100 and $24.0000 per share under a 10b5-1 trading plan, leaving 193,009 common shares held directly.
Insider Trade Summary 10b5-1
Exercise and Sale: 5,800 shares ($91K approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
Cook Steven L.
Role
Chief Financial Officer
Sold
5,800 shs ($139K)
Approx. gross sale proceeds
$139K
Approx. exercise cost
$48K
Approx. pre-tax spread
$91K
Share of Position Sold
3.0%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F2 | 5,800 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,800 | $8.28 | $48K |
| Sale | Common Stock F1 | 5,200 | $24.00 | $125K |
| Sale | Common Stock F1 | 600 | $24.01 | $14K |
Holdings After Transaction:
Stock Option (Right to Buy) — 261,845 contracts (Direct);
Common Stock — 187,209 shares (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 267,645 to 261,845 contracts (Direct);
Common Stock, 187,209 to 187,209 shares (Direct)
Other Insiders: 3 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (2)
- F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
- F2. 100% of the shares subject to the option are fully vested and exercisable.
Key Figures
Shares sold: 5800 shares
Sale prices: $24.0100 and $24.0000 per share
Options exercised: 5800 shares at $8.2800 per share
+3 more
6 metrics
Shares sold
5800 shares
Total Common Stock sold in open-market transactions on July 13, 2026
Sale prices
$24.0100 and $24.0000 per share
Per-share prices for 600-share and 5200-share Common Stock sales
Options exercised
5800 shares at $8.2800 per share
Common shares acquired through exercise of Stock Option (Right to Buy) on July 13, 2026
Common shares held after
193009 shares
Direct Common Stock ownership following the reported transactions
Stock options held after
261845 options
Stock Option (Right to Buy) derivative securities following the option exercise
Option expiration date
2031-07-19
Expiration date of the Stock Option (Right to Buy) grant exercised in part
Key Terms
10b5-1 trading plan, Stock Option (Right to Buy), derivative security, open-market sale
4 terms
10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted"
A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.
Stock Option (Right to Buy) financial
"Security title listed as Stock Option (Right to Buy)"
derivative security financial
"Exercise or conversion of derivative security is noted in the description"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"Transaction action described as open-market sale of Common Stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Omada Health (OMDA) report for its CFO?
Omada Health reported that CFO Steven L. Cook exercised options for 5,800 common shares and sold 5,800 common shares in open-market transactions on July 13, 2026, as disclosed in a Form 4 filing.
What stock options did Omada Health (OMDA) CFO exercise in this filing?
He exercised a Stock Option (Right to Buy) covering 5,800 underlying common shares at an exercise price of $8.2800 per share. The option expires on July 19, 2031, and footnotes state that 100% of the shares subject to the option are fully vested.
Were the Omada Health (OMDA) insider sales made under a 10b5-1 trading plan?
Yes. A footnote states the transactions were made pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2026, indicating the trades were pre-arranged rather than discretionary market-timing decisions.
What derivative position remains for Omada Health (OMDA) CFO after this Form 4?
For the reported Stock Option (Right to Buy), the Form 4 shows 261,845 derivative securities following the transaction. This reflects the remaining option position of that grant type as of July 13, 2026, separate from his common share holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
